651 Neurological adverse events associated with immune checkpoint inhibitors: Our experience in a tertiary care center

• Pablo Alvarez-Ballesteros,
• Javier Buisan-Catevilla,
• Alvaro Beltrán-Corbellini,
• Iñigo Corral-Corral,
• Javier Pozas-Perez,
• Victor Albarran-Fernandez,
• Lucia Sanz-Gomez,
• Jorge Esteban-Villarrubia,
• Javier Torres-Jimenez,
• Jesús Chamorro-Perez,
• Diana Rosero-Rodriguez,
• María San Román-Gil,
• Ainara Soria-Rivas

Affiliations

Pablo Alvarez-Ballesteros

Ramon y Cajal University Hospital, Madrid, Spain

Javier Buisan-Catevilla

Ramon y Cajal University Hospital, Madrid, Spain

Alvaro Beltrán-Corbellini

Ramon y Cajal University Hospital, Madrid, Spain

Iñigo Corral-Corral

Ramon y Cajal University Hospital, Madrid, Spain

Javier Pozas-Perez

Ramon y Cajal University Hospital, Madrid, Spain

Victor Albarran-Fernandez

Ramon y Cajal University Hospital, Madrid, Spain

Lucia Sanz-Gomez

Ramon y Cajal University Hospital, Madrid, Spain

Jorge Esteban-Villarrubia

Ramon y Cajal University Hospital, Madrid, Spain

Javier Torres-Jimenez

Ramon y Cajal University Hospital, Madrid, Spain

Jesús Chamorro-Perez

Ramon y Cajal University Hospital, Madrid, Spain

Diana Rosero-Rodriguez

Ramon y Cajal University Hospital, Madrid, Spain

María San Román-Gil

Ramon y Cajal University Hospital, Madrid, Spain

Ainara Soria-Rivas

Ramon y Cajal University Hospital, Madrid, Spain